Citations

Clear

1011 citation(s) found for "Barry, WT".

Detection of Left Atrial Myopathy Using Artificial Intelligence–Enabled Electrocardiography
Verbrugge, Frederik H. , Reddy, Yogesh N.V. , Attia, Zachi I. , Friedman, Paul A. , Noseworthy, Peter A. , López-Jiménez, Francisco , Borlaug, Barry A. , Kapa, Suraj , Borlaug, Barry A , Noseworthy, Peter A , Nishimura, Rick , Lopez-Jimenez, Francisco , Attia, Zachi I , Verbrugge, Frederik H , Kapa, Suraj

Mayo Clinic

Circulation: Heart Failure | December 16, 2021 | Volume: 15 | Issue: 1 | Pages: No page available

10.1161/circheartfailure.120.008176 | PMID 34911362 Get It

Background: Left atrial (LA) myopathy is common in patients with heart failure and preserved ejection fraction and leads to the development of atrial fibrillation (AF). We investigated whether the likelihood of LA remodeling, LA dysfunction, altered hemodynamics, and risk for incident AF could be identified from a single 12-lead ECG using a novel artificial intelligence (AI)-enabled ECG analysis. Methods: Patients with heart failure and preserved ejection fraction (n=613) underwent AI-enabled ECG analysis, echocardiography, and cardiac catheterization. Individuals were grouped by AI-enabled ECG probability of contemporaneous AF, taken as an indicator of underlying LA myopathy. Results: Structural heart disease was more severe in patients with higher AI-probability of AF, with more left ventricular hypertrophy, larger LA volumes, and lower LA reservoir and booster strain. Cardiac filling pressures and pulmonary artery pressures were higher in patients with higher AI-probability, while cardiac output reserve was more impaired during exercise. Among patients with sinus rhythm and no prior AF, each 10% increase in AI-probability was associated with a 31% greater risk of developing new-onset AF (hazard ratio, 1.31 [95% CI, 1.20–1.42]; P <0.001). In the population as a whole, each 10% increase in AI-probability was associated with a 12% greater risk of death (hazard ratio, 1.12 [95% CI, 1.08–1.17]; P <0.001) during long-term follow-up, which was no longer significant after adjustments for baseline characteristics. Conclusions: A novel AI-enabled score derived from a single 12-lead ECG identifies the presence of underlying LA myopathy in patients with heart failure and preserved ejection fraction as evidenced by structural, functional, and hemodynamic abnormalities, as well as long-term risk for incident AF. Further research is required to determine the role of the AI-enabled ECG in the evaluation and care of patients with heart failure and preserved ejection fraction.
Resting and Exercise Haemodynamic Characteristics of Patients with Advanced Heart Failure and Preserved Ejection Fraction
Deis, Tania , Wolsk, Emil , Mujkanovic, Jasmin , Komtebedde, Jan , Heyden, Jan Van der , Petrie, Mark C. , Kahwash, Rami , Hoendermis, Elke S., Hummel, Scott L. , Gustafsson, Finn , Hummel, Scott L , Petrie, Mark C , Gustafsson, Finn , Burkhoff, Daniel , Kaye, David M. , Hasenfuß, Gerd , Hayward, Chris , Shah, Sanjiv J , Borlaug, Barry A. , Litwin, Sheldon E.

Mayo Clinic

ESC Heart Failure | December 8, 2021 | Volume: 9 | Issue: 1 | Pages: 186-195

10.1002/ehf2.13697 | PMID 34877822 Get It

Abstract Aims This study aimed to describe haemodynamic features of patients with advanced heart failure with preserved ejection fraction (HFpEF) as defined by the Heart Failure Association (HFA) of the European Society of Cardiology (ESC). Methods and results We used pooled data from two dedicated HFpEF studies with invasive exercise haemodynamic protocols, the REDUCE LAP-HF (Reduce Elevated Left Atrial Pressure in Patients with Heart Failure) trial and the REDUCE LAP-HF I trial, and categorized patients according to advanced heart failure (AdHF) criteria. The well-characterized HFpEF patients were considered advanced if they had persistent New York Heart Association classification of III–IV and heart failure (HF) hospitalization &lt; 12 months and a 6 min walk test distance &lt; 300 m. Twenty-four (22%) out of 108 patients met the AdHF criteria. On evaluation, clinical characteristics and resting haemodynamics were not different in the two groups. Patients with AdHF had lower work capacity compared with non-advanced patients (35 ± 16 vs. 45 ± 18 W, P = 0.021). Workload-corrected pulmonary capillary wedge pressure normalized to body weight (PCWL) was higher in AdHF patients compared with non-advanced (112 ± 55 vs. 86 ± 49 mmHg/W/kg, P = 0.04). Further, AdHF patients had a smaller increase in cardiac index during exercise (1.1 ± 0.7 vs. 1.6 ± 0.9 L/min/m2, P = 0.028). Conclusions A significantly higher PCWL and lower cardiac index reserve during exercise were observed in AdHF patients compared with non-advanced. These differences were not apparent at rest. Therapies targeting the haemodynamic compromise associated with advanced HFpEF are needed.
Faculty Opinions recommendation of Inhibition of phosphodiesterase type 9 reduces obesity and cardiometabolic syndrome in mice.
Borlaug, Barry A.

Mayo Clinic

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature | November 29, 2021 | Volume: No volume available | Issue: No issue available | Pages: No page available

10.3410/f.740948663.793589991 Get It

Faculty Opinions recommendation of Energetic Basis for Exercise-Induced Pulmonary Congestion in Heart Failure With Preserved Ejection Fraction.
Borlaug, Barry A.

Mayo Clinic

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature | November 29, 2021 | Volume: No volume available | Issue: No issue available | Pages: No page available

10.3410/f.741174652.793589990 Get It

Changes in inferior vena cava area represent a more sensitive metric than changes in filling pressures during experimental manipulation of intravascular volume and tone
Wetterling, Friedrich , Gaul, Robert , Sheridan, Stephen, Asher, Jennifer L. , Rao, Veena S. , Mahoney, Devin , Mebazaa, Alexandre , Gray, Alastair , Cowie, Martín , Fudim, Marat , McDonald, Kenneth , Damman, Kevin , Cowie, Martin R , Ivey-Miranda, Juan B , Maulion, Christopher , Burkhoff, Daniel , Cox, Zachary L , Butler, Javed , Borlaug, Barry A. , Testani, Jeffrey M.

Mayo Clinic

European Journal of Heart Failure | November 27, 2021 | Volume: 24 | Issue: 3 | Pages: 455-462

10.1002/ejhf.2395 | PMID 34837447 Get It

Aims Remote monitoring of pulmonary artery pressure has reduced heart failure (HF) hospitalizations in chronic HF as elevation of pulmonary artery pressure provides information that can guide treatment. The venous system is characterized by high capacitance, thus substantial increases in intravascular volume can occur before filling pressures increase. The inferior vena cava (IVC) is a highly compliant venous conduit and thus a candidate for early detection of change in intravascular volume. We aimed to compare IVC cross‐sectional area using a novel sensor with cardiac filling pressures during experimental manipulation of volume status, vascular tone, and cardiac function. Methods and results Experiments were conducted in sheep to manipulate volume status (colloid infusion), vascular tone (nitroglycerin infusion) and cardiac function (rapid cardiac pacing). A wireless implantable IVC sensor was validated ex‐vivo and in‐vivo , and then used to measure the cross‐sectional area of the IVC. Right‐ and left‐sided cardiac filling pressures were obtained via right heart catheterization. The IVC sensor provided highly accurate and precise measurements of cross‐sectional area in ex‐vivo and in‐vivo validation. IVC area changes were more sensitive than the corresponding changes in cardiac filling pressures during colloid infusion ( p < 0.001), vasodilatation ( p < 0.001) and cardiac dysfunction induced by rapid pacing ( p ≤ 0.02). Conclusions Inferior vena cava area can be remotely and accurately measured in real time with a wireless implantable sensor. Changes in IVC area are more sensitive than corresponding changes in filling pressures following experimental volume loading and fluid redistribution. Additional research is warranted to understand if remote monitoring of the IVC may have advantages over pressure‐based monitors in HF.
Ex Vivo and In Vivo CD46 Receptor Utilization by Species D Human Adenovirus Serotype 26 (HAdV26)
Hemsath, Jack R. , Liaci, A. Manuel , Rubin, Jeffrey D. , Parrett, Brian J. , Lu, Shao‐Chia , Turner, Mallory A., Chen, Christopher Y. , Cupelli, Karolina, Reddy, Vijay , Stehle, Thilo , Liszewski, M. Kathryn , Atkinson, John P. , Barry, Michael A. , Stehle, Thilo , Barry, Michael A , Nguyen, Tien Anh

Mayo Clinic

Journal of Virology | November 17, 2021 | Volume: 96 | Issue: 3 | Pages: No page available

10.1128/jvi.00826-21 | PMID 34787457 Get It

The human species D Ad26 is being investigated as a low-seroprevalence vector for oncolytic virotherapy and gene-based vaccination against HIV-1 and SARS-CoV-2. However, there is debate in the literature about its tropism and receptor utilization, which directly influence its efficiency for certain applications. This work was aimed at determining which receptor(s) this virus uses for infection and its role in virus biology, vaccine efficacy, and, importantly, vaccine safety.
Quality of Life and Exercise Ability in Heart Failure With Preserved Ejection Fraction
Redfield, Margaret M. , Borlaug, Barry A.

Mayo Clinic

JAMA | November 16, 2021 | Volume: 326 | Issue: 19 | Pages: 1913

10.1001/jama.2021.15874 | PMID 34783856 Get It

Uncoupling between intravascular and distending pressures leads to underestimation of circulatory congestion in obesity
Reddy, Yogesh N.V. , Sorimachi, Hidemi, Borlaug, Barry A. , Obokata, Masaru , Melenovský, Vojtěch , Borlaug, Barry A , Nishimura, Rick , Jarolı́m, Petr

Mayo Clinic

European Journal of Heart Failure | November 9, 2021 | Volume: 24 | Issue: 2 | Pages: 353-361

10.1002/ejhf.2377 | PMID 34755429 Get It

Abstract Aims Patients with obesity frequently present with dyspnoea. Biomarkers that reflect wall stress are often used to evaluate circulatory congestion and help determine whether dyspnoea is of cardiac causes. Patients with obesity display greater external restraint on the heart, which may alter relationships between intravascular pressures and stress markers. Methods and results Subjects with unexplained dyspnoea ( n = 212) underwent cardiac catheterization with simultaneous echocardiography. Blood sampling was performed in a subset ( n = 58). Relationships between echocardiographic and blood biomarkers of circulatory congestion and directly‐measured haemodynamics were compared between participants with severe obesity [body mass index (BMI) ≥35 kg/m 2 , Group B) and those without (BMI <35 kg/m 2 , Group A). Circulatory congestion was assessed by pulmonary capillary wedge pressure (PCWP), and vascular distending pressure was assessed by left ventricular transmural pressure (LVTMP). As compared to Group A, participants in Group B displayed higher PCWP relative to N‐terminal pro‐B‐type natriuretic peptide, mid‐regional pro‐atrial natriuretic peptide, troponin T, and growth differentiation factor‐15 (all p < 0.01). In contrast, the relationships between LVTMP and the biomarkers were superimposable. Echocardiographic biomarkers revealed the same pattern: PCWP was higher for any E/e′ ratio in Group B compared to Group A, but the relationship between LVTMP and E/e′ was similar. In contrast, levels of C‐terminal pro‐endothelin‐1 and mid‐regional pro‐adrenomedullin were more robustly correlated with PCWP (r = 0.67 and r = 0.62, both p < 0.0001), with no differential relationship based upon BMI. Conclusions Non‐invasive haemodynamic markers underestimate circulatory congestion in patients with obesity, an effect that appears related to uncoupling between cardiac wall stress and intravascular pressures. This may lead to systematic under‐recognition of congestion in patients with obesity.